Phase II Study Evaluating the Addition of Cetuximab to the Concurrent Delivery of Weekly Carboplatin, Paclitaxel, and Daily Radiotherapy for Patients With Locally Advanced Squamous Cell Carcinomas of the Head and NeckMohan Suntharalingam, Kevin J. Cullen, Robert A. Ord et al.|International Journal of Radiation Oncology*Biology*Physics|2011Cited by 36
Race impacts outcome in stage III/IV squamous cell carcinomas of the head and neck after concurrent chemoradiation therapyKathleen Settle, Mohan Suntharalingam, R. Taylor et al.|Cancer|2009Cited by 27
Patterns of failure among patients with squamous cell carcinoma of the head and neck who obtain a complete response to chemoradiotherapySusannah Yovino, Mohan Suntharalingam, Kathleen Settle et al.|Head & Neck|2009Cited by 15
Site as a Prognostic Factor in Patients With Stage III/IV Squamous Cell Carcinoma of the Head and Neck Following Definitive ChemoradiationK. Carter, M. Suntharalingam, Ann B. Zimrin et al.|International Journal of Radiation Oncology*Biology*Physics|2007Cited by 2